Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2010-10-04 |
| Study Made Public: | 2012-02-14 |
Title
Evaluation of gp41 MPER based liposomes in inducing neutralizing antibodies
Description
CAVD 341 is an immunogenicity study of broadly neutralizing antibodies evaluating gp41 MPER based liposomes in inducing neutralizing antibodies.
Sign in to see full information about this study and to download study data.
Products
Carbopol R2-gp145 DNA gp41-FD liposome gp41-CHRTM liposome C-terminal-Cys liposome Empty liposome R2 proteinIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.